Cannabinoid Synthesis via Palladium Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing cannabinoids are inefficient and costly, requiring extensive chromatographic purification and often result in impurities, making it difficult to produce substantially pure cannabinoids like Δ9-tetrahydrocannabinol, and are uneconomic on a large scale due to the use of expensive reagents and acidic reaction conditions.
Innovation Solution
A process involving a cascade sequence of allylic rearrangement, aromatization, and highly stereoselective cyclization to produce Δ9-cannabinoids from simple inexpensive starting materials, minimizing the formation of undesired Δ8-isomers and allowing for the synthesis of both known and novel cannabinoids, including Δ9-tetrahydrocannabinol, tetrahydrocannabivarin, cannabidiol, and cannabidivarin, using a palladium catalyst and mild bases to achieve regioselective and stereoselective cyclization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthesis methods are used to produce cannabinoids, then cannabinoids can be obtained, but extensive chromatographic purification is required and impurities are formed
Solution Approach 1:
The patent applies preliminary action by designing a synthesis route that pre-establishes the correct stereochemistry and regiochemistry through chiral pool synthesis and catalytic asymmetric synthesis. This preliminary configuration of molecular structure prevents the formation of unwanted isomers and impurities, thereby eliminating the need for extensive chromatographic purification steps later in the process.
Solution Approach 2:
The invention takes out the purification step entirely by designing a synthesis method that produces cannabinoids with high purity directly. Instead of synthesizing cannabinoids and then removing impurities through chromatography, the method extracts the problem at its source by ensuring only the desired product is formed through stereoselective and regioselective reactions.
2Ease of manufacture
If conventional synthesis methods are used, then cannabinoids are produced, but expensive reagents and acidic reaction conditions are required making it uneconomic on large scale
Solution Approach 1:
The patent applies parameter changes by modifying the reaction conditions from conventional acidic environments to mild basic or neutral conditions. This parameter change enables the use of cheaper, more scalable reagents and catalysts while maintaining high product purity and yield, making the synthesis economically viable for large-scale production.
Solution Approach 2:
The invention employs cheap, readily available starting materials from the chiral pool such as amino acids and sugars, replacing expensive specialized reagents. These inexpensive, easily obtainable materials can be used on large scale without significant cost penalty, enabling economical manufacturing.
3Manufacturing precision
If conventional methods are used to synthesize Δ9-tetrahydrocannabinol, then the compound can be produced, but substantial purification difficulty arises
Solution Approach 1:
The patent uses chiral pool compounds such as amino acids and sugars as intermediaries that already possess the required stereochemical configuration. These chiral intermediaries serve as building blocks that transfer their stereochemistry to the final Δ9-tetrahydrocannabinol product through stereoselective reactions, ensuring high purity without requiring separation of isomers.
Solution Approach 2:
The invention replaces the mechanical separation process (chromatography) with a chemical approach (stereoselective synthesis). Instead of physically separating desired product from impurities using chromatographic columns, the method uses chemical selectivity in the synthesis step to produce only the desired stereoisomer, thereby substituting a complex mechanical purification system with a more efficient chemical synthesis approach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the efficient and reproducible production of cannabinoids with low levels of undesired isomers, reducing costs and simplifying purification, allowing for the synthesis of both known and novel cannabinoids suitable for pharmaceutical applications.
Implementation Method 1
using a palladium catalyst and mild bases to achieve regioselective and stereoselective cyclization
Implementation Method 2
A process involving a cascade sequence of allylic rearrangement, aromatization, and highly stereoselective cyclization
Implementation Method 3
highly stereoselective cyclization to produce Δ9-cannabinoids from simple inexpensive starting materials
Data Source
AI summary
The use of a medicament as a single agent, binary agent, or other combination comprising of substantially pure novel cannabinoids 1 and 2, optionally admixed with one or more known and novel cannabinoids and other known naturally occurring and synthetic tetracyclic 2A and tricyclic 1A cannabinoids for the prevention, treatment or cure of inflammatory mediated diseases or inflammatory mediated pathological conditions, anorexia, arthritis, cancer, pain, glaucoma, migraine, persistent muscle spasms, seizures (epileptic seizures), severe nausea, PTSD, autism spectrum disorder, drug abuse, insomnia, or any other chronic or persistent medical symptom.